BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 22740385)

  • 1. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
    Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
    Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
    Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity troponin T levels in kidney transplant recipients.
    Arroyo D; Quiroga B; Panizo N; Rodríguez-Ferrero M; Macías N; Reque J; Anaya F; Luño J
    Transplant Proc; 2012 Nov; 44(9):2545-7. PubMed ID: 23146449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D
    Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
    Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
    Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
    J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study).
    Das SR; Abdullah SM; Leonard D; Drazner MH; Khera A; McGuire DK; de Lemos JA
    Am J Cardiol; 2008 Nov; 102(10):1394-8. PubMed ID: 18993162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C; Manzoor S; Wright J; Roberts SA; Wood G; McDowell G; Kalra PA
    Kidney Blood Press Res; 2009; 32(5):373-9. PubMed ID: 19887825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
    J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals.
    Schou M; Alehagen U; Goetze JP; Gustafsson F; Dahlstrom U
    Heart; 2009 Sep; 95(18):1514-9. PubMed ID: 19570761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
    Takase H; Dohi Y
    Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease.
    Otsuka T; Kawada T; Seino Y; Ibuki C; Katsumata M; Kodani E
    Am J Cardiol; 2010 Nov; 106(10):1456-60. PubMed ID: 21059436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Lehmann N; Neumann T; Kälsch H; Möhlenkamp S; Dykun I; Broecker-Preuss M; Pundt N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
    Int J Cardiol; 2015 Mar; 183():155-61. PubMed ID: 25666125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
    Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.